THERAPEUTICS
Adolescents with SSRI-resistant depression: CBT plus antidepressant switch more effective than medication switch alone
| The first 150 words of the full text of this article appear below. |
What is the best strategy for adolescents with depression who dont respond to initial SSRIs?
334 adolescents (12–18 years old) with a primary diagnosis of major depressive disorder who had not responded to a 2-month trial with an SSRI. Main exclusions: non-response to
2 trials of an SSRI or to venlafaxine (
4 weeks at dose
150 mg) or CBT (
7 sessions); already receiving CBT; taking psychoactive medications (except those on stable doses of stimulants or hypnotics for
12 weeks); bipolar spectrum disorder; psychosis; pervasive developmental disorder or autism; eating disorders; or substance abuse or dependence.
US academic and community clinics; 2000–2006.
One of four 12-week regimens: switch to a second, different SSRI (paroxetine, fluoxetine or citalopram at 20–40 mg daily); switch to venlafaxine (150–225 mg daily); switch to second SSRI plus CBT; switch to venlafaxine plus CBT. CBT was delivered by experienced therapists with at least masters level
Locum Consultant in Adolescent Psychiatry, Lancaster, and Honorary Lecturer, University of Manchester, UK
Register for free content
The full back archive is now available for all BMJ Journals. Institutional subscribers may access the entire archive as part of their subscription. Personal subscribers will also have access to all content when logged in. Non-subscribers who register have free access to all articles published before 2006 right back to volume 1 issue 1. Register here to access the free archive of all BMJ Journals.
Don't forget to sign up for content alerts so you keep up to date with all the articles as they are published.
